General Info
Ron Seubert is the founder of RareCyte, Inc., a company that focuses on characterizing and isolating rare cells in the blood, providing tools for cancer and cardiovascular research. He has a significant track record in developing innovative technologies and collaborating with industry experts. Previous investments include RareCyte, with a focus on life science research and diagnostics. Specific partnership and collaboration styles are not explicitly mentioned, but Ron Seubert engages in webinars and collaborations within the industry.
Location: Seattle, Washington, United States
Country: United States of America
Industries:
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a June 27, 2024 financing for RareCyte that lists Ron Seubert as an investor (RareCyte). The time since that investment is about 4 months and some days (from June 27, 2024 to early November 2024 would be >4 months; using the required reference date results in under 6 months), so classification is very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Ron Seubert
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI